Filter results

Induced Pluripotent Stem Cells clinical trials

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

View clinical trials related to Induced Pluripotent Stem Cells.

Filter by:

Withdrawn
Page 1

NCT ID: NCT02056613 Withdrawn - Clinical trials for Induced Pluripotent Stem Cells

Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products

Start date: February 5, 2014
Phase:
Study type: Observational

Background: - Pluripotent stem cells are cells that can be converted to any type of cell (muscle, nerve, liver, etc.). Researchers are collecting blood samples to develop way to make a special cell product called induced pluripotent stem cells (iPSCs). iPSCs may be used to repair or replace organs and tissues, produce blood and immune cells for transfusion, or correct inherited immune and blood diseases. iPSCs can be made from many kinds samples, such as skin, blood, or hair. This is different from embryonic stem cells, which can only be derived from embryos. Objectives: - To develop new methods to make iPSCs; to identify better ways to collect, produce, and grow them; and to make an iPSC bank. Eligibility: - Healthy adults and adults already in a treatment protocol who have a medical condition that could be treated with iPSCs. Design: - All participants will be screened with questionnaire, physical exam, and blood and HIV tests. - All participants: - Will donate 4 tablespoons of blood. It will be taken by needle from a vein in their arm. - Participants already in another protocol: - Will have their blood collected, separated in a lab, and iPSCs grown in large numbers. Some may have their sample given back to them as a treatment. - Samples will be kept in the study up to 5 years or until a participant withdraws from the study or becomes ineligible to participate, or the study is closed. If participants have not withdrawn their consent, they may be contacted in the future to donate again.